Retrospective public health impact of a quadrivalent influenza vaccine in the United States

Vaccination is an effective preventive strategy against influenza. However, current trivalent influenza vaccines (TIVs) contain only one of the two influenza B lineages that circulate each year. Vaccine mismatches are frequent because predicting which one will predominate is difficult. Recently licensed quadrivalent influenza vaccines (QIVs) containing the two B lineages should address this issue. Our study estimates their impact by assessing what would have been the US public health benefit of routinely vaccinating with QIV in 2000–2013.

[1]  W John Edmunds,et al.  Estimating the impact of childhood influenza vaccination programmes in England and Wales. , 2008, Vaccine.

[2]  K. Clements,et al.  Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States , 2014, Human vaccines & immunotherapeutics.

[3]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[4]  M. Decker,et al.  Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. , 2013, Vaccine.

[5]  松本 慶蔵,et al.  季節性インフルエンザ(Seasonal Influenza)の総括 , 2009 .

[6]  N. Ferguson,et al.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.

[7]  C. Bauch,et al.  Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis , 2013, BMC Medicine.

[8]  M. Saville,et al.  Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. , 2013, Vaccine.

[9]  Richard White,et al.  An Introduction to Infectious Disease Modelling , 2010 .

[10]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[11]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[12]  C. Hannoun,et al.  The evolving history of influenza viruses and influenza vaccines , 2013, Expert review of vaccines.

[13]  S. Plotkin,et al.  Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. , 2012, Vaccine.

[14]  E. Zagheni,et al.  Using time-use data to parameterize models for the spread of close-contact infectious diseases. , 2008, American journal of epidemiology.

[15]  Sarah M Bartsch,et al.  The economic value of a quadrivalent versus trivalent influenza vaccine. , 2012, Vaccine.

[16]  C. Reed,et al.  Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. , 2012, Vaccine.

[17]  G. Meier,et al.  The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model , 2014, PloS one.

[18]  M. Decker,et al.  Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age , 2014, The Pediatric infectious disease journal.

[19]  R. Mikolajczyk,et al.  Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.